Medical Technology

@xconomy.com 3 years ago

Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More

@xconomy.com 3 years ago

Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More

@xconomy.com 4 years ago

Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 4 years ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 5 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 5 years ago

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

@xconomy.com 5 years ago

Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 6 years ago

CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”